Investigating the Link between Circadian Clock Gene Expressions, Chronotype, Insomnia, and Daytime Sleepiness in Patients with Obstructive Sleep Apnea.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
21 Aug 2024
Historique:
received: 13 07 2024
revised: 16 08 2024
accepted: 19 08 2024
medline: 31 8 2024
pubmed: 31 8 2024
entrez: 29 8 2024
Statut: epublish

Résumé

This study aimed to investigate the relationship between obstructive sleep apnea (OSA), circadian rhythms, and individual sleep-wake preferences, as measured by chronotype, and to assess the association between circadian clock gene expression and subjective sleep-related variables. A total of 184 individuals were recruited, underwent polysomnography (PSG), and completed questionnaires including a chronotype questionnaire (CQ), insomnia severity index (ISI), and Epworth sleepiness scale (ESS). Blood samples were collected in the evening before and morning after PSG. Gene expression analysis included BMAL1, CLOCK, PER1, CRY1, NPAS2, and NR1D1. In the OSA group, the subjective amplitude (AM score of CQ) positively correlated with all circadian clock genes in the morning (R ≥ 0.230 and The findings highlight the complex interplay between OSA, circadian rhythms, and sleep-related variables, suggesting potential determinants of morning chronotype in OSA and implicating disrupted circadian clock function in subjective feelings of energy throughout the day. Further research is warranted to elucidate underlying mechanisms and guide personalized management strategies.

Identifiants

pubmed: 39201748
pii: ijms25169062
doi: 10.3390/ijms25169062
pii:
doi:

Substances chimiques

ARNTL Transcription Factors 0
CLOCK Proteins EC 2.3.1.48
BMAL1 protein, human 0
CRY1 protein, human 0
Cryptochromes 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Science Centre, Poland
ID : 2018/31/N/NZ5/03931

Auteurs

Agata Gabryelska (A)

Department of Sleep Medicine and Metabolic Disorder, Medical University of Lodz, 92-216 Lodz, Poland.

Szymon Turkiewicz (S)

Department of Sleep Medicine and Metabolic Disorder, Medical University of Lodz, 92-216 Lodz, Poland.

Adrian Gajewski (A)

Department of Immunology and Allergy, Medical University of Lodz, 92-215 Lodz, Poland.

Piotr Białasiewicz (P)

Department of Sleep Medicine and Metabolic Disorder, Medical University of Lodz, 92-216 Lodz, Poland.

Dominik Strzelecki (D)

Department of Affective and Psychotic Disorders, Medical University of Lodz, 92-216 Lodz, Poland.

Maciej Chałubiński (M)

Department of Immunology and Allergy, Medical University of Lodz, 92-215 Lodz, Poland.

Marcin Sochal (M)

Department of Sleep Medicine and Metabolic Disorder, Medical University of Lodz, 92-216 Lodz, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH